Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1844, Issue 5, 2014, Pages 1051-1058

  Humphries, Julia M ^a   Penno, Megan A S ^a   Weiland, Florian ^a   Klingler Hoffmann, Manuela ^a   Zuber, Agnieszka ^a   Boussioutas, Alex ^b,c   Ernst, Matthias ^d   Hoffmann, Peter ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Biomarkers; Intestinal type gastric adenocarcinoma; Isoforms; Post translational modifications; Serum proteomics

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBODY; BIOLOGICAL MARKER; CAFAMINOL; CLUSTERIN; HAPTOGLOBIN; ISOPROTEIN; PROTEIN; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; ISOELECTRIC FOCUSING; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SERUM; STOMACH ADENOCARCINOMA; STOMACH CANCER; VALIDATION STUDY; WESTERN BLOTTING;

BIOMARKERS; INTESTINAL-TYPE GASTRIC ADENOCARCINOMA; ISOFORMS; POST-TRANSLATIONAL MODIFICATIONS; SERUM PROTEOMICS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN; ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CASE-CONTROL STUDIES; CLUSTERIN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL DISEASES; GLYCOPROTEINS; HAPTOGLOBINS; HUMANS; MALE; MASS SPECTROMETRY; MICE; MIDDLE AGED; NEOPLASM STAGING; PROTEOME; PROTEOMICS; ROC CURVE; SERUM ALBUMIN; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VITAMIN D-BINDING PROTEIN;

EID: 84898876600     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2014.01.018     Document Type: Article

References (25)

1. H. Brenner, D. Rothenbacher, and V. Arndt Epidemiology of stomach cancer Methods Mol. Biol. 472 2009 467 477
2. J.C. Layke, and P.P. Lopez Gastric cancer: diagnosis and treatment options Am. Fam. Physician 69 5 2004 1133 1140
3. C. Hamashima et al. The Japanese guidelines for gastric cancer screening Jpn. J. Clin. Oncol. 38 4 2008 259 267 (Pubitemid 351583989)
4. M. Nishizawa Present status and prospect for cancer screening J. Gastroenterol. Mass Survey 78 1993 100 103
5. H. Nakata et al. Transnasal and standard transoral endoscopies in the screening of gastric mucosal neoplasias World J. Gastrointest. Endosc. 3 8 2011 162 170
6. L. Brandt Patients' attitudes and apprehensions about endoscopy: how to calm troubled waters Am. J. Gastroenterol. 96 2001 280 284
7. R. Hart, and M. Classen Complications of diagnostic gastrointestinal endoscopy Endoscopy 22 1990 229 233 (Pubitemid 20334034)
8. E. Bough, and S. Meyers Cardiovascular responses to upper gastrointestinal endoscopy Am. J. Gastroenterol. 69 1978 655 661 (Pubitemid 9013827)
9. W.K. Leung et al. Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice Lancet Oncol. 9 3 2008 279 287 (Pubitemid 351722947)
10. D. Marrelli et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma Oncology 57 1 1999 55 62 (Pubitemid 29308672)
11. K. Lam, and S. Lo Discovery of diagnostic serum biomarkers of gastric cancer using proteomics Proteomics Clin. Appl. 2 2 2008 219 228 (Pubitemid 351284901)
12. J. Norton Surgery: Basic Science and Clinical Evidence 2001 Springer
13. M.P. Ebert, and C. Rocken Molecular screening of gastric cancer by proteome analysis Eur. J. Gastroenterol. Hepatol. 18 2006 847 853 (Pubitemid 44034797)
14. F. Riedel et al. Serum levels of interleukin 6 in patients with primary head and neck squamous cell carcinoma Anticancer Res. 25 2005 2761 2766 (Pubitemid 41044658)
15. J.F. Rusling et al. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer Analyst 135 2010 2496 2511
16. W. Liu et al. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis Clin. Chim. Acta 377 1-2 2007 119 126 (Pubitemid 44908239)
17. S. Surinova et al. On the development of plasma protein biomarkers J. Proteome Res. 10 2011 5 16
18. M. Penno et al. 2D-DIGE analysis of sera from transgenic mouse models reveals novel candidate protein biomarkers for human gastric cancer J. Proteomics 77 2012 40 58
19. N. Ahmed et al. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer Proteomics 5 17 2005 4625 4636 (Pubitemid 41739939)
20. Z. Zhang et al. Isoform-level expression profiles provide better cancer signatures than gene-level expression profiles Genome Med. 5 4 2013 33
21. M. McKay et al. The development of multiple reaction monitoring assays for liver-derived plasma proteins Proteomics Clin. Appl. 1 12 2007 1570 1581
22. S. Randall, M. McKay, and M. Molloy Evaluation of blood collection tubes using selected reaction monitoring MS: implications for proteomic biomarker studies Proteomics 10 2010 2050 2056
23. M. Penno, M. Ernst, and P. Hoffmann Comparative 2D DIGE analysis of the depleted serum proteome for biomarker discovery Methods Mol. Biol. 854 2012 207
24. R. Kondrat, G. McClusky, and R. Cooks Multiple reaction monitoring in mass spectrometry/mass spectrometry for direct analysis of complex mixtures Anal. Chem. 50 1978 2017 2021
25. L. Anderson, and C.L. Hunter Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 5 4 2006 573 588